Quizartinib
>98%
- Product Code: 102223
CAS:
950769-58-1
| Molecular Weight: | 560.67 g./mol | Molecular Formula: | C₂₉H₃₂N₆O₄S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Quizartinib is primarily used in the treatment of acute myeloid leukemia (AML), particularly for patients with FLT3-ITD mutations. It functions as a potent and selective FLT3 inhibitor, targeting the mutated FLT3 receptor tyrosine kinase, which is often associated with aggressive disease progression. By inhibiting this mutation, quizartinib helps to slow down or stop the growth of cancer cells. It is typically administered to patients who have relapsed or are refractory to other treatments, offering a targeted therapeutic option. Clinical trials have demonstrated its efficacy in improving overall survival and remission rates in this specific patient population. Additionally, it is sometimes used in combination with other chemotherapy agents to enhance its effectiveness.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Off-White Solid |
| Purity (%) | 98 |
| Nmr | Consistent With Structure |
| Infrared Spectrum | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿792.00 |
+
-
|
Quizartinib
Quizartinib is primarily used in the treatment of acute myeloid leukemia (AML), particularly for patients with FLT3-ITD mutations. It functions as a potent and selective FLT3 inhibitor, targeting the mutated FLT3 receptor tyrosine kinase, which is often associated with aggressive disease progression. By inhibiting this mutation, quizartinib helps to slow down or stop the growth of cancer cells. It is typically administered to patients who have relapsed or are refractory to other treatments, offering a targeted therapeutic option. Clinical trials have demonstrated its efficacy in improving overall survival and remission rates in this specific patient population. Additionally, it is sometimes used in combination with other chemotherapy agents to enhance its effectiveness.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :